Information Provided By:
Fly News Breaks for July 26, 2016
ALKS
Jul 26, 2016 | 06:24 EDT
Cowen analyst Chris Shibutani upgraded Alkermes to Outperform and raised its price target to $60 form $50 saying the sustainability and strong sales growth for Vivitrol remains underappreciated. The analyst raised Alkermes estimates above consensus from 2016-2020 and said increasing appreciation for the magnitude of the positive inflection in Vivitrol's sales will provide compelling case for further shares outperformance.
News For ALKS From the Last 2 Days
There are no results for your query ALKS
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.